Cargando…

Menopausal hormone therapy and ovarian cancer

Detalles Bibliográficos
Autor principal:	Baber, Rod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Invited Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604667/ https://www.ncbi.nlm.nih.gov/pubmed/26538985 http://dx.doi.org/10.4103/0976-7800.165587

Ejemplares similares

Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020)

Postmenopausal bleeding: Which endometrial thickness is safe in menopausal hormone therapy users?
por: Dreisler, Eva
Publicado: (2022)

Talking about menopause in the workplace
por: Carter, Sarah, et al.
Publicado: (2021)

Menopause and personal protective equipment: How does this meet acceptable working conditions?
por: Kydd, Angela
Publicado: (2021)

COVID-19 and hormonal contraception
por: Cagnacci, Angelo, et al.
Publicado: (2022)

Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study
por: Trabert, B, et al.
Publicado: (2012)

Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis
por: Liu, Yang, et al.
Publicado: (2019)

Menopausal Hormone Therapy, can we safely use it in women with co-morbidities?
por: Shah, Duru
Publicado: (2015)

Diagnostic challenges in suspected premature ovarian insufficiency
por: Armeni, Eleni
Publicado: (2022)

Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015)

Menopausal hormone therapy after breast cancer
por: Colditz, Graham A
Publicado: (2005)

Effects of Menopausal Hormone Therapy on Uterine Myoma in Menopausal Women
por: Chang, IK Jin, et al.
Publicado: (2013)

Emirati Women’s Knowledge about the Menopause and Menopausal Hormone Therapy
por: Smail, Linda, et al.
Publicado: (2020)

Ovarian Tissue-Based Hormone Replacement Therapy Recovers Menopause-Related Signs in Mice
por: Yoo, Dahyeon, et al.
Publicado: (2022)

Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression
por: Feng, Ninghan, et al.
Publicado: (2019)

Guidelines and recommendations on hormone therapy in the menopause
por: Pines, Amos
Publicado: (2010)

Menopausal hormone therapy and venous thromboembolism
por: Bińkowska, Małgorzata
Publicado: (2014)

The 2020 Menopausal Hormone Therapy Guidelines
por: Lee, Sa Ra, et al.
Publicado: (2020)

Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy
por: Gava, Giulia, et al.
Publicado: (2019)

Effect of Menopausal Hormone Therapy on the Vaginal Microbiota and Genitourinary Syndrome of Menopause in Chinese Menopausal Women
por: Geng, Lulu, et al.
Publicado: (2020)

San Antonio Breast Cancer Symposium 2007—Adjuvant endocrine therapy update: ATAC 100 highlights
por: Joy, Anil A.
Publicado: (2008)

Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
por: De Angelis, Carlo
Publicado: (2008)

Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible
por: Banks, Emily, et al.
Publicado: (2010)

Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study
por: Felix, Ashley S., et al.
Publicado: (2015)

Controversies in testosterone supplementation therapy
por: Khera, Mohit
Publicado: (2015)

Bioidentical Hormones for Menopausal Hormone Therapy: Variation on a Theme
por: Fugh-Berman, Adriane, et al.
Publicado: (2007)

Menopause Hormone Therapy in the Changing Trends of Breast Cancer in India
por: Meeta, Meeta, et al.
Publicado: (2020)

Update on Menopausal Hormone Therapy for Fracture Prevention
por: Stepan, Jan J., et al.
Publicado: (2019)

Ovarian tissue bank for fertility preservation and anti-menopause hormone replacement
por: Chen, Jing, et al.
Publicado: (2022)

The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK
por: Rosario, Derek J., et al.
Publicado: (2016)

Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine
por: Gaffo, Angelo L, et al.
Publicado: (2008)

Conclusions about testosterone therapy and cardiovascular risk
por: Anawalt, Bradley D, et al.
Publicado: (2018)

The Winning Line Up: Positioning Advanced Therapies for Ulcerative Colitis
por: Forster, Erin M
Publicado: (2023)

Use of novel drug therapies during pregnancy and breast-feeding
por: Ayuk, Paul T.-Y.
Publicado: (2023)

The Role of Menopausal Hormone Therapy in Reducing All-cause Mortality in Postmenopausal Women Younger than 60 Years: An Adaptive Meta-analysis
por: Bae, Jong-Myon, et al.
Publicado: (2018)

A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause
por: Madsen, Tracy E, et al.
Publicado: (2023)

Bronchopleural fistula treatment: From the archetype of surgery to the future of stem cell therapy
por: Petrella, Francesco, et al.
Publicado: (2015)

Predicting the outcome of normal pressure hydrocephalus therapy—where do we stand?
por: Oertel, Joachim M. K., et al.
Publicado: (2021)

2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
por: Banach, Maciej, et al.
Publicado: (2022)

Hormone naïve prostate cancer: predicting and maximizing response intervals
por: Moul, Judd W
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dblh25p1ncd7u4s4e785ug07op